NEWS

Jul 1, 2019
Dr. Wiliam J. Pavan and his team at National Human Genome Research Institute (NHGRI) have established a novel diagnostic tool to predict time of onset for the rare neurodegenerative Niemann-Pick disease type C (NPC). The npc1 gene mutation leads to...
Apr 30, 2019
NCI research team, led by Dr. Mark Schiffman at Division of Cancer Epidemiology and Genetics (DCEG), is conducting a “Cervix Image Sharing Protocol (CISP)” study on artificial intelligence (AI) approach for better and low-cost screening and...
Apr 24, 2019
The European medical innovation journal, MedNous, featured a story in its March issue entitled “NCI and Industry: Moving Innovations from the Lab to Patients” authored by Michael Salgaller and Michele Newton. MedNous is both a print and online...

New & Updated Opportunities

Jun 28, 2019

The treatment of cancer using immunotherapies has garnered substantial attention and excitement following clinical benefit observed in patient populations previously...

Jun 28, 2019

Interleukin (IL)-34 is a homodimer that is produced mainly by keratinocytes, neuronal cells and regulatory T cells (Tregs). It is believed to play important roles in...

Jun 28, 2019

T cell immunotherapy is used in the treatment of various pathologies – including cancers and infections. Current therapies employ chimeric antigen receptors (CARs)...

SPOTLIGHT

The Cure Sickle Cell Initiative was launched by the National Heart, Lung, and Blood Institute (NHLBI) to build a nationwide commitment in finding new treatments and personalized care for this hereditary red blood cell disorder. Sickle cell disease affects about 100,000 Americans, many of whom are African American, and over 20 million people worldwide. Since founded in 1948, NHLBI has the long tradition of advancing research on understanding of the sickle cell disease and improving its clinical care. NHLBI also offers many sickle cell disease resources, including publications and videos to help patients and health professionals to learn about treatment and pain management strategies.

Cure Sickle Cell Initiative will actively engage and positively motivate the sickle cell disease community of patients, family members, caregivers, academic institutions, advocacy groups, pharmaceutical companies, federal agencies and biotechnology companies to work together on a path to...

Read More...